GenXys Health Care Systems

What GenXys Health Care Systems does

GenXys Health Care Systems Inc. is a private Vancouver-based SaaS company founded at the University of British Columbia in 2014-2015 that provides a precision prescribing platform with embedded pharmacogenetics (PGx). The company's core offering, GenXys One, is a prescribing orchestration platform that ingests pharmacogenetic variants alongside patient health records—kidney and liver function, drug-drug interactions, allergies, contraindications, and comorbidities—to generate personalized, evidence-based medication recommendations. Clinical logic is curated against the Clinical Pharmacogenetics Implementation Consortium (CPIC), the Dutch Pharmacogenetics Working Group (DPWG), and FDA Table of Pharmacogenetic Associations, covering 200+ gene-medication associations, 750+ medications, and 30+ conditions. The product suite includes TreatGx (clinical decision support), ReviewGx (medication therapy management automation), LabGx (PGx reporting with SmartStart onboarding for laboratories), IdentifyPGx (variant identification), and OptimizeGx (prior authorization, biosimilars, and utilization alignment). The platform is delivered as cloud-native SaaS on Microsoft Azure with HITRUST certification, supporting HL7/FHIR interoperability and integration into EHR, LIMS, and pharmacy systems.

The company operates a horizontal enterprise go-to-market across four segments: clinical and genomic laboratories (40+ supported, 40,000+ PGx reports generated), health systems, payers and pharmacy benefit managers, and biopharma. Distribution blends direct enterprise field sales with a channel partner strategy spanning laboratory resellers (Inagene, SRx Health, Immunogenomics of Texas, Flexsus, LifeLabs), LIS providers (Dendi), and PBMs (TrueScripts). Pricing is quote-based annual enterprise SaaS subscription; reported commercial metrics include 100% enterprise customer renewal rate, implementation timelines under 30 days, and 349% year-over-year quarterly sales growth in Q1 2023. Cumulative capital raised is approximately $3.5M across a 2018 seed round and a 2020 round led by GreenShield with participation from TELUS Global Ventures and Esplanade Ventures. Geographic footprint spans nearly 25% of US states and Canada, with stated expansion plans into Asia and Europe, supported by ongoing global clinical studies.

Name

GenXys Health Care Systems

Legal name

GenXys Health Care Systems Inc.

Website

https://genxys.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

GenXys Health Care Systems provides a cloud-based SaaS precision prescribing platform with embedded pharmacogenetics grounded in CPIC/DPWG guidelines, serving clinical laboratories, health systems, payers, PBMs, and biopharma across North America with evidence-based clinical decision support.

Ownership category

akta.pro rank

Product category

Pharmacogenomics Clinical Decision Support Software

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Pharmacogenomics (PGx) Decision Support (HLAAANAB)

akta.pro secondary industries

Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools (HLACAKAH), Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG)

Keywords

• Pharmacogenomic decision support
• Precision prescribing software
• Clinical decision support
• Medication therapy management
• Pharmacogenetic testing platform

Headquarters

HQ city

Vancouver

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations

Revenue model

1. SaaS Platform Licensing: Software-as-a-service subscription model providing access to the GenXys prescribing orchestration platform. Licensed to laboratories, health systems, payers, PBMs, and biopharma companies. Pricing likely quote-based for enterprise tier with potential per-report or per-user components.
2. Clinical Decision Support Software Suite: Clinical decision support software suite license providing precision prescribing solutions with embedded pharmacogenetics. In use by major insurance providers, health systems, pharmacies and their pharmacogenetic labs across North America.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

GenXys Health Care Systems develops and licenses a cloud-based Prescribing Orchestration Platform (GenXys One) that integrates pharmacogenetic data with patient health records to deliver evidence-based, personalized medication recommendations. The platform's modular products — TreatGx clinical decision support, ReviewGx medication therapy management automation, LabGx PGx reporting for laboratories, and OptimizeGx access/utilization optimization — are licensed as SaaS subscriptions to clinical laboratories, health systems, payers, PBMs, and biopharmaceutical companies.

Product overview

GenXys Health Care Systems provides a Prescribing Orchestration Platform with a modular architecture. The core GenXys One platform connects healthcare data, decisions, access, workflows, and outcomes across laboratories, health systems, payers, PBMs, and biopharma. Key products include TreatGx (clinical decision support system for personalized treatment recommendations), ReviewGx (medication therapy management automation), LabGx (PGx reporting for laboratories), IdentifyPGx (genetic variant identification), OptimizeGx (access and utilization optimization), and CDSS (precision prescribing module). These products integrate pharmacogenetics with patient health data to provide evidence-based prescribing intelligence.

Differentiator

Problem solved

Functional benefit

Products and services

• GenXys One Prescribing Orchestration Platform The core cloud-based prescribing orchestration platform that connects data, decisions, access, workflows, and outcomes into configurable intelligence for laboratories, health systems, payers, PBMs, and biopharma. Built on Microsoft Azure with a governed intelligence core and configurable workflow agents.
• TreatGx Clinical Decision Support System (CDSS) Precision prescribing clinical decision support software that integrates pharmacogenomic data with patient health records to identify personalized treatment options and optimal drug dosing within a clinician's workflow. Considers pharmacogenetics, kidney function, liver function, contraindications, allergies, drug-drug interactions, and other patient-specific factors.
• ReviewGx Medication Therapy Management Software Medication therapy management automation software that combines evidence-based pharmacogenetics, deprescribing insights, clinical lab data, and other patient-specific information to support comprehensive medication review.
• LabGx PGx Reporting Module PGx reporting module built for modern clinical and genomic laboratories with configurable interpretation, customizable reports, and integration-ready workflows. Includes SmartStart onboarding for qualified labs and supports LIMS, instrumentation outputs, and EHR-ready data via HL7/FHIR.
• OptimizeGx Access and Utilization Optimization Module Optimization module that aligns prescribing actions with coverage, criteria, evidence, and documentation needs for access and utilization management, including prior authorization and biosimilar routing.
• TreatGxPlus Pharmacogenetic Testing Service Co-branded pharmacogenetic testing service that combines LifeLabs cheek-swab DNA analysis (covering 60 genetic variations) with GenXys medication decision support software, making pharmacogenetic testing available to Canadians through a Canadian-owned solution.

Quantifiable outcome

• 349% year-over-year quarterly sales growth in Q1 2023
• +3 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability4 records

Feature5 records

Partnerships

Twelve partnerships are on record, tiered minor and core.

• Agena BioscienceminorGTM or Marketing Partner · 25 March 2026Webinar collaboration with Agena Bioscience on implementing DPYD pharmacogenomics testing in laboratory settings. Joint presentation of consensus recommendations and practical workflow strategies for translating clinical guidelines into routine PGx testing practice.
• XtalksminorGTM or Marketing Partner · 25 March 2026Xtalks hosting a free webinar on implementing DPYD pharmacogenomics testing, with speakers from GenXys and Agena Bioscience presenting consensus recommendations and practical workflow strategies to laboratories and health systems.
• CareWell HealthcoreChannel Partner/ Reseller/ Distributor · 20 June 2023Software deal with New Jersey-based CareWell Health (top three hospital in NJ) for precision medicine implementation. GenXys precision prescribing software with embedded PGx provides automated medication review capabilities and seamless connection between laboratory and care teams.
• DendicoreTechnology or Integration · 17 May 2023Partnership with Dendi, a leading laboratory information system provider, to deliver tightly-integrated PGx interpretation and clinical decision support. The collaboration provides comprehensive test results and treatment recommendations through a technology-driven workflow, addressing the underserved PGx market in clinical settings.
• Microsoft AzurecoreTechnology or Integration · 27 February 2023Cloud infrastructure partnership using Microsoft Azure IaaS and PaaS offerings. Azure enables GenXys to support many thousands of clinicians with country-specific patient and genetic database environments meeting local privacy, security, and storage regulations. HITRUST-certified infrastructure provides disaster recovery and dynamic performance scalability.
• TrueScriptscoreChannel Partner/ Reseller/ Distributor · 11 January 2023Partnership with Indiana-based TrueScripts, a pharmacist-founded PBM with network of 70,000 pharmacies across the USA. GenXys CDSS integrates pharmacogenomics into TrueScripts' clinical workflow for precision medicine adoption across their member base.
• Manchester UniversityminorGTM or Marketing Partner · 1 November 2022Partnership with Manchester University for pharmacogenomics education. Together GenXys and Manchester University drive global awareness and education of pharmacogenomics as a field.
• InagenecoreChannel Partner/ Reseller/ Distributor · 28 July 2022North American laboratory company partnership extending GenXys market coverage for pharmacogenetics tools and precision prescribing software.
• SRx HealthcoreChannel Partner/ Reseller/ Distributor · 28 July 2022North American laboratory company partnership extending GenXys market coverage for pharmacogenetics tools and precision prescribing software.
• Immunogenomics of TexascoreChannel Partner/ Reseller/ Distributor · 28 July 2022North American laboratory company partnership extending GenXys market coverage for pharmacogenetics tools and precision prescribing software.
• Flexsus (FlexHealth)coreChannel Partner/ Reseller/ Distributor · 19 May 2022Partnership with Ohio-based Flexsus, the laboratory division of FlexHealth, to advance precision medicine initiatives with GenXys software solutions.
• LifeLabscoreStrategic or Co-development Partner · 14 June 2017Partnership with Canada's largest community laboratory (LifeLabs) to offer the TreatGxPlus pharmacogenetic testing service. LifeLabs performs DNA analysis on cheek swab samples for 60 genetic variations, with results integrated into GenXys medication decision support software. This partnership made pharmacogenetic testing available to Canadians through a Canadian-owned solution.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• OneOme: OneOme provides pharmacogenomic clinical decision support through its RightMed platform, closely matching GenXys' TreatGx offering. Several GenXys advisors (e.g., Paul Owen, Morgan Donaldson) are OneOme alumni, underscoring direct competitive overlap in PGx-guided prescribing for clinicians and labs.
• YouScript (Invitae): YouScript delivers PGx-based medication decision support integrated with EHRs and lab workflows — a near-direct competitor to GenXys TreatGx/LabGx, particularly in health-system and clinical-laboratory channels.
• Molecular Health: Molecular Health offers genomic clinical decision support and treatment-guidance software, overlapping with GenXys' algorithmic decision engine and curated PGx logic. Both target precision prescribing and oncology/medication selection use cases.
• Translational Software: Translational Software provides PGx reporting and clinical decision support for laboratories and clinicians, directly competing with GenXys' LabGx and TreatGx modules across lab reporting and point-of-care prescribing workflows.
• Coriell Life Sciences: Coriell Life Sciences combines pharmacogenetic interpretation with medication decision support, serving healthcare providers and laboratories in a manner comparable to GenXys' precision prescribing platform.
• Genomind: Genomind offers PGx testing coupled with clinical decision support for mental health and broader prescribing, overlapping with GenXys' chronic-condition and specialty medication decision support use cases.

Broad incumbents

• First Databank (FDB): FDB provides drug knowledge and medication decision support used widely across EHRs and health systems. As a broad incumbent, it offers overlapping drug-interaction and dosing support but does not natively focus on PGx-driven prescribing like GenXys.
• Wolters Kluwer (Medication Decision Support): Wolters Kluwer's clinical decision support portfolio (e.g., Lexicomp, Medi-Span) provides medication guidance embedded in major EHRs. It is a broader incumbent competing for the prescribing-intelligence workflow that GenXys targets.
• Epic Genomics (Epic Systems): Epic's genomics module integrates genetic results and basic decision support into its dominant EHR platform. As a broad incumbent, it overlaps with GenXys' health-system EHR integration strategy but is not PGx-specialized.

Emerging players

• Color Health: Color Health provides genetic testing with an expanding clinical decision support layer, partially overlapping GenXys' lab-reporting and clinical workflow offerings. It is an emerging player moving up-stack from testing toward prescribing intelligence.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/MyGenXys

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds2 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GenXys Health Care Systems